Trials / Completed
CompletedNCT02488915
Analysis of Revascularization in Ischemic Stroke With EmboTrap
ARISE II (Analysis of Revascularization in Ischemic Stroke With EmboTrap) Study
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 228 (actual)
- Sponsor
- Neuravi Inc. · Industry
- Sex
- All
- Age
- 18 Years – 85 Years
- Healthy volunteers
- Not accepted
Summary
The study objective is to examine the recanalization efficacy of the EmboTrap device and its associated performance characteristics and to record associated clinical outcomes in a manner that facilitates relevant comparison of outputs with that of devices approved in the U.S. for clearing Large Vessel Occlusions.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | EmboTrap® Revascularization Device |
Timeline
- Start date
- 2015-11-01
- Primary completion
- 2017-05-01
- Completion
- 2017-09-01
- First posted
- 2015-07-02
- Last updated
- 2018-07-13
- Results posted
- 2018-07-13
Locations
12 sites across 4 countries: United States, Belgium, Germany, Ireland
Source: ClinicalTrials.gov record NCT02488915. Inclusion in this directory is not an endorsement.